Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

被引：0
|
作者：
Reece, Donna E.
Masih-Khan, Esther [1 ]
Khan, Arooj [1 ]
Dean, Saima [1 ]
Fung, Sharon [2 ]
Anglin, Peter [4 ]
Chen, Christine
Kukreti, Vishal
Mikhael, Joseph R. [3 ]
Trudel, Suzanne [5 ]
机构：
[1] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada
[2] Princess Margaret Hosp, Dept Biostat, Toronto, ON M4X 1K9, Canada
[3] Mayo Clin Arizona, Scottsdale, AZ USA
[4] Southlake Reg Canc Ctr, Newmarket, ON, Canada
[5] Princess Margaret Hosp, McLaughlin Ctr Mol Med, Toronto, ON M4X 1K9, Canada
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1260 / 1260
页数：1
相关论文
共 50 条
  • [21] Phase I/II study of bortezomib, lenalidomide, and dexamethasone treatment for relapsed and refractory multiple myeloma
    Mori, Yasuo
    Choi, Ilseung
    Yoshimoto, Goichi
    Muta, Tsuyoshi
    Yamasaki, Satoshi
    Tanimoto, Kazuki
    Kamimura, Tomohiko
    Iwasaki, Hiromi
    Ogawa, Ryosuke
    Akashi, Koichi
    Miyamoto, Toshihiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (05) : 673 - 680
  • [22] Phase I Trial of Ibrutinib, Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
    Ailawadhi, Sikander
    Paulus, Aneel
    Alegria, Victoria R.
    Laplant, Betsy
    Moustafa, Muhamad Alhaj
    Chapin, Dustin
    Jackson, Keisha
    Jani, Prachi
    Ahmed, Salman
    Edwards, Brett
    Manna, Alak
    Roy, Vivek
    Sher, Taimur
    Chanan-Khan, Asher A.
    BLOOD, 2019, 134
  • [23] A phase I trial of ruxolitinib, lenalidomide, and methylprednisolone for patients with relapsed/refractory multiple myeloma (MM).
    Berenson, James R.
    To, Jennifer
    Spektor, Tanya M.
    Martinez, Daisy
    Sanchez, Armando Jose
    Ghermezi, Matthew
    Turner, Carley
    Swift, Regina A.
    Eades, Benjamin M.
    Schwartz, Gary
    Eshaghian, Shahrooz
    Stampleman, Laura
    Moss, Robert A.
    Nassir, Youram
    Patel, Ravindranath
    Bessudo, Alberto
    Lim, Stephen
    Vescio, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results
    Ailawadhi, Sikander
    Parrondo, Ricardo D.
    Moustafa, Muhamad Alhaj
    LaPlant, Betsy R.
    Alegria, Victoria
    Chapin, Dustin
    Roy, Vivek
    Sher, Taimur
    Paulus, Aneel
    Chanan-Khan, Asher A.
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 695 - 703
  • [25] Phase II Trial of Lenalidomide (Revlimid™) with Cyclophosphamide and Dexamethasone (RCd) for Newly Diagnosed Myeloma
    Kumar, Shaji
    Hayman, Suzanne
    Buadi, Francis
    Lacy, Martha
    Stewart, Keith
    Allred, Jacob
    Lauman, Kristina
    McCarty, Tammy
    Bergsagel, Leif
    Dingli, David
    Fonseca, Rafael
    Gertz, Morie
    Greipp, Philip
    Lust, John
    Russell, Stephen
    Reeder, Craig
    Wilzig, Thomas
    Zeldenrust, Steven
    Kyle, Robert
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    BLOOD, 2008, 112 (11) : 40 - 40
  • [26] Phase 2 clinical Trial of Oral Lenalidomide, Cyclophosphamide, and prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
    Suvannasankha, Attaya
    Farag, Sherif
    Obryant, Robin
    Wood, Lisa I.
    Porter, Nicole
    Abonour, Rafat
    BLOOD, 2010, 116 (21) : 823 - 823
  • [27] Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
    Suvannasankha, Attaya
    Farag, Sherif
    O'Bryant, Robin A.
    Wood, Lisa L.
    Abonour, Rafat
    BLOOD, 2009, 114 (22) : 1125 - 1125
  • [28] Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma
    Reece, Donna E.
    Trieu, Young
    Masih-Khan, Esther
    Atenafu, Eshetu G.
    Chen, Christine
    Prica, Anca
    Tiedemann, Rodger
    Trudel, Suzanne
    Kukreti, Vishal
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (07): : 387 - 394
  • [29] Pomalidomide Cyclophosphamide and Prednisone (PCP) Treatment for Relapsed/Refractory Multiple Myeloma
    Palumbo, Antonio
    Larocca, Alessandra
    Montefusco, Vittorio
    Rossi, Davide
    Carella, Angelo Michele
    Mina, Roberto
    Crippa, Claudia
    Sciacca, Mariella
    Galli, Monica
    Scalabrini, Delia Rota
    Marcatti, Magda
    Guglielmelli, Tommasina
    Giuliani, Nicola
    La Verde, Giacinto
    Baldi, Ileana
    Muccio, Vittorio Emanuele
    Boccadoro, Mario
    Corradini, Paolo
    BLOOD, 2012, 120 (21)
  • [30] A Phase II Trial of Chloroquine in Combination with Bortezomib and Cyclophosphamide in Patients with Relapsed and Refractory Multiple Myeloma
    Montanari, Francesca
    Lu, Meina
    Marcus, Sara
    Saran, Ankeeta
    Malankar, Aditya
    Mazumder, Amitabha
    BLOOD, 2014, 124 (21)
12345